American Bio Medica Increases Share in Corrections Market.

Business Editors

KINDERHOOK, N.Y.--(BUSINESS WIRE)--Jan. 6, 2000

American Bio Medica Corp. (NASDAQ: ABMC) today announced that it is rapidly increasing its market share in the criminal/juvenile justice and corrections industry.

The Company said that it has purchase agreements in many states, including Connecticut, Florida, Idaho, Maine, Montana and South Carolina. American Bio Medica explained that its corrections marketing strategy identifies sheriff's offices, police departments, adult and juvenile facilities, probation and parole offices, drug courts and pretrial agencies at the federal, state and county levels.

"I am pleased to report our continued success in navigating the state bidding process and listing ABMC as an approved vendor with county, state and federal criminal justice facilities," stated American Bio Medica CEO and Chairman Stan Cipkowski. "These achievements once again demonstrate the Rapid Drug Screen's competitive and cost advantages, which are unique features that the Company continues to leverage in capturing further market share within the corrections sector.

American Bio Medica Corporation develops, manufactures and markets inexpensive, accurate, on-site drugs of abuse diagnostic kits and support services worldwide. The Company's global distributors target the workplace, clinical, physicians, corrections and educational markets. ABMC's Rapid Drug Screen(TM) is proven to correlate 100% with the standard laboratory screening test.

Forward-looking statements in this release are made pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking statements involve risk and uncertainties, including without limitation, continued acceptance of the Company's products, increased levels of competition for the Company, new products and technological changes, the Company's dependence on third-party suppliers, intellectual property rights and other risks detailed from time to time in the Company's periodic reports filed with the Securities and Exchange Commission.